The Validity and Reliability of the Turkish Version of the Heart Failure Somatic Perception Scale

NCT06681714 | Not Yet Recruiting

• 1 other identifier: SBA 24/702
• Study Type: observational
• Target: 100
• Locations: 1 country
• Sites: 1

Brief Summary

The aim of this study is to evaluate The Validity and Reliability of the Turkish Version of the Heart Failure Somatic Perception Scale in patients with heart failure.

Conditions

Heart Failure

Outcome Measures

Primary Outcomes (1)

• The Heart Failure Somatic Perception Scale

  The Heart Failure Somatic Perception Scale comprises 18 items that assess how much the main signs and symptoms of heart failure have distressed the individual over the past week. Each item is rated on a five-point Likert scale, ranging from 0, indicating "did not experience this symptom," to 5, indicating "severe distress." The total score is obtained by summing the scores of all items, yielding a range from 0 to 90. A higher score indicates a greater impact of heart failure symptoms on the patient's life. Turkish version of The Heart Failure Somatic Perception Scale will be applied.

  1 day

Secondary Outcomes (7)

• The Heart Failure Symptom Status Scale

  1 day

• Mini mental test

  1 day

• The MacNew Heart Disease-Specific Quality of Life Questionnaire

  1 day

• Charlson Comorbity Index

  1 day

• The Minnesota Living with Heart Failure Questionnaire

  1 day

Study Arms (1)

Heart Failure

Patients with heart failure

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Patients with heart failure

You may qualify if:

• A diagnosis of heart failure. Use of optimal pharmacological treatment according to current guidelines for at least 3 months.
• Functional capacity classified as New York Heart Association (NYHA) Class I-IV (ambulatory).
• Age 18 or older. Ability to cooperate with measurements.

You may not qualify if:

• Known cognitive impairment. Having undergone acute coronary syndrome, percutaneous coronary intervention, or heart surgery within the past three months.

Sponsors & Collaborators

• Hacettepe University: lead

Study Sites (1)

Hacettepe University

Ankara, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Heart Failure

Condition Hierarchy (Ancestors)

Heart Diseases; Cardiovascular Diseases

Study Officials

• Aynur Demirel, PT, PhD

  Hacettepe University

  PRINCIPAL INVESTIGATOR

Central Study Contacts

Aynur Demirel, PT, PhD

CONTACT

+905545295057; aynur.demirel@hacettepe.edu.tr

Hidaye Yamikan, PT,MSc

CONTACT

hidaye.yamikan@hacettepe.edu.tr

Study Design

• Study Type: observational
• Observational Model: CASE CONTROL
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: PT, PhD

Study Record Dates

• First Submitted: November 7, 2024
• First Posted: November 8, 2024
• Study Start: December 9, 2024
• Primary Completion: June 9, 2025
• Study Completion (Estimated): December 9, 2026
• Last Updated: November 8, 2024

Record last verified: 2024-11

Locations

TU (1)